InvestorsHub Logo
Followers 439
Posts 45331
Boards Moderated 4
Alias Born 05/11/2008

Re: whytestocks post# 1062

Wednesday, 10/21/2020 9:53:37 AM

Wednesday, October 21, 2020 9:53:37 AM

Post# of 3504
Building on our growth strategy are the assets we will acquire from Cleveland BioLabs, as well as the drug development tools and services obtained with the acquisition of ImQuest Life Sciences. These two transactions represent a transformative growth opportunity, not only for Cytocom, but also for the shareholders of both Cleveland BioLabs and ImQuest Life Sciences.

that sounds very good.

imo a buy and hold for the next 5 years